Rockwell Medical (RMTI) Projected to Post Quarterly Earnings on Thursday

Rockwell Medical (NASDAQ:RMTI) is anticipated to announce its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $23.65 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Rockwell Medical Price Performance

RMTI opened at $1.73 on Wednesday. The stock has a fifty day moving average of $1.89 and a 200-day moving average of $2.64. The firm has a market capitalization of $55.91 million, a P/E ratio of -34.60 and a beta of 1.55. Rockwell Medical has a 12-month low of $1.38 and a 12-month high of $5.15. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33.

Wall Street Analyst Weigh In

RMTI has been the subject of a number of research analyst reports. HC Wainwright restated a “buy” rating and issued a $7.00 target price on shares of Rockwell Medical in a report on Monday, December 23rd. StockNews.com lowered Rockwell Medical from a “buy” rating to a “hold” rating in a report on Friday, December 20th.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.